Clinico-Demographic Profile of Paediatric Patients with Primary Intracranial Tumours in South India

Nitin Joseph1, Ravikiran Sr2, Prithu A R Sagar3

  • 1Department of Community Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka India.

PubMed

Insights

Pediatric central nervous system cancers, particularly intracranial tumors, present diagnostic challenges due to non-specific symptoms. This study highlights medulloblastoma as the most common type in children, with vomiting being the most frequent symptom and Temozolomide the primary treatment.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Clinical Research

Background:

  • Central and peripheral nervous system cancers are the second most common cancers in children (0-14 years).
  • Diagnosing pediatric intracranial tumors is challenging due to non-specific clinical presentations.
  • Understanding the socio-demographic profile, clinical features, and management of these tumors is crucial.

Purpose of the Study:

  • To investigate the socio-demographic characteristics of pediatric patients with intracranial tumors.
  • To identify the common clinical features and presenting symptoms of these tumors.
  • To analyze the management practices and treatment outcomes for pediatric intracranial tumors.

Main Methods:

  • A cross-sectional, medical record-based study was conducted.
  • Data were collected from 31 pediatric patients (<18 years) diagnosed with primary intracranial tumors.
  • A semi-structured proforma was used to record socio-demographic data, clinical features, tumor characteristics, and management.

Main Results:

  • The median age at diagnosis was 7 years, with a majority of patients being male (54.8%).
  • Medulloblastoma was the most frequent tumor type (38.7%), predominantly in the infratentorial region (58.1%).
  • Vomiting (58.1%) was the most common symptom, and most tumors were Stage III/IV (64.5%). Chemotherapy was used in 74.2% of patients, with Temozolomide being the most common drug.

Conclusions:

  • Male gender and medulloblastoma are common in pediatric intracranial tumors.
  • Advanced tumor stages (III/IV) and vomiting are prevalent clinical findings.
  • Chemotherapy, particularly Temozolomide, is a primary treatment modality for these pediatric cancers.